|
SEARCH
|
It’s one of the most devastating and economically damaging pig diseases in the world: Porcine circovirus associated disease (PCVAD). It can strike early or appear in a late form. And once it strikes, the consequences are never good.
Since the 1990s, the world has seen a dramatic increase in the porcine circovirus type 2 (PCV2) virus loads in pigs. This prolific virus impairs the immune system and leaves pigs susceptible to other swine diseases. Pneumonia, PMWS, enteritis, respiratory disease, porcine dermatitis and nephropathy syndrome… those are just some of the diseases caused by PCV2 that can affect pigs suddenly and with devastating results:
Dramatic increase in mortality 
The hardy and environmentally stable circovirus can be transmitted:
And although replication stimuli are not completely understood, it is believed there is slow replication prior to “stimulus.”
Multiple cofactors may increase viral load:
In addition, viral load can be influenced by PCV2 virus isolate, age, and genetic factors.
Diagram courtesy of Dr. Pat Halbur, DVM, PhD, Iowa State University, Ames, IA
The clinical signs of PCVAD can mimic many diseases, which is why an accurate diagnosis is critical for appropriate control measures. The Boehringer Ingelheim Swine Health Management Center and other veterinary diagnostic laboratories can confirm PCVAD cases with testing.
Common signs include:
Clinical signs typically appear in pigs 9 to 12 days post-infection, with mortality beginning 10 to 21 days. Pigs are viremic for 21 days (3 weeks) or more and secondary infections and symptoms can persist for up to 42 days (6 weeks).
The best protection against the prevalence of PCV2 is a combination of biosecurity, accurate diagnostics, vaccination and disease management processes.
Boehringer Ingelheim Vetmedica, Inc. is committed to supporting advanced research and diagnostic and product development programs that provide practical solutions to PCVAD and other diseases that impact swine production.
Click here to download this webpage as a PDF.
References
1. Cline, G., Wilt, V., Diaz, E., Efficacy of Ingelvac CircoFLEX in pigs vaccinated at 3 and 6 weeks of age in a PRRS and Mycoplasma hyopneumoniae-negative production system, Leman Conference 2007.